In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Canadian biotech Oncolytics raises $2.3mm in IPO

Executive Summary

Synsorb Biotech's subsidiary Oncolytics Inc. of Calgary, Alberta (developing a reovirus as a cancer treatment) has grossed $2.3mm ($Cdn3.4mm) in its initial public offering in Canada. It sold 4mm common shares at $Cdn0.85 apiece.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO
    • Spin-Off

Related Companies